Evidence map›Paper›PMID 33997398›Full record

ArticleHeliyon2021

Evaluation of body composition in patients with migraine on prophylactic treatment with topiramate.

Camila Naegeli Caverni, Aline Turbino da Costa, Caio Grava Simioni, Rosemeire Rocha Fukue, Celia Harumi Tengan, Thais Rodrigues Villa

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Camila Naegeli CaverniDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Aline Turbino da CostaDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Caio Grava SimioniDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Rosemeire Rocha FukueDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Celia Harumi TenganDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Thais Rodrigues VillaDepartment of Neurology & Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Migraine is a primary headache with high prevalence in the general population but is considered a disabling medical condition. It is suggested that obesity is a risk factor for chronic migraine. Thus treatment with drugs, such as topiramate, which reduces pain and weight, is ideal for obese patients with migraine. The aim of this study was to evaluate the effects of topiramate on body composition in patients with chronic migraine and to verify whether these effects could be related to nutritional status. We studied 26 female patients with age ranging from 18 to 45 years with prophylactic treatment with topiramate (50 mg/day) for three months. Body composition indexes (body mass index, BMI; body fat, BF; fat-free mass, FFM) were obtained through anthropometric assessment. After treatment, topiramate reduced BMI (0,82 kg/m

Indexed as

Body compositionChronic migraineFat free massMigraineTopiramate

Identifiers

PMID33997398
PMCPMC8099645
OpenAlexW3159396261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.